Immune checkpoint inhibitors (ICIs) have improved the landscape of cancer research over the past decade. These therapies, which target a patient’s own immune system aiming to make it stronger and more ...

Polyrizon Ltd. Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective solutions today announced positive results from ...

Combination of AT7687 and cagrilintide demonstrated enhanced weight loss effect in obese, insulin-resistant, pre-diabetic non-human primate (NHP) ...

BRAINTREE, Mass., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (MBOT), developer of the innovative LIBERTY ® Endovascular Robotic Surgical System, today announces the successful completion ...

Polyrizon (PLRZ) announced “positive” results from a new in-vitro pre-clinical study evaluating the allergen-blocking performance of its PL-14 ...

- Single-dose administration of LAE102 by IV or SC injection demonstrated a favorable safety profile in the healthy participants as well as robust and prolonged target engagement in the healthy ...

(RTTNews) - Microbot Medical Inc. (MBOT) announced Thursday the successful completion of its GLP pivotal pre-clinical study, done under the guidelines of FDA-required levels of planning, controlling, ...

Artelo Biosciencs ARTL were up 46% on Aug 16, during market hours, after the company announced positive initial data from a pre-clinical study for one of its novel inhibitors to fatty acid binding ...

Database locks for studies on actinic keratosis (AK) and acne vulgaris achieved on January 5, 2026Data generated will support ...

Immune cells, known as T cells (also called T lymphocytes), play a vital role in the anti-tumor immune response. T cells find, attack, and, when effective, kill cancer cells. Adoptive cell transfer ...